One of them studied an EGFR-directed CAR-T cell with inducible production and the release of transgenic IL-12 cytokine (NCT03542799), which is capable of modulating the tumour microenvironment and attracting and activating innate immune cells to attack the tumour [36]. The gene discussed is EGFR; the disease is neoplasm.